Report overview
When injections and pills are counter-indicated, transdermal and transmucosal delivery systems may get drugs into the body with great efficacy and beneficial results.
This report aims to provide a comprehensive presentation of the global market for Transdermal and Transmucosal Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal and Transmucosal Drug Delivery. This report contains market size and forecasts of Transdermal and Transmucosal Drug Delivery in global, including the following market information:
Global Transdermal and Transmucosal Drug Delivery Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Transdermal and Transmucosal Drug Delivery market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Transdermal Drug Delivery Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Transdermal and Transmucosal Drug Delivery include 3M, Antares Pharma, Aveva Drug Delivery Systems, Corium International, DURECT, Pantec Biosolutions, Tapemark and Tesa Labtec, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Transdermal and Transmucosal Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Transdermal and Transmucosal Drug Delivery Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Transdermal and Transmucosal Drug Delivery Market Segment Percentages, by Type, 2022 (%)
Transdermal Drug Delivery
Transmucosal Drug Delivery
Global Transdermal and Transmucosal Drug Delivery Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Transdermal and Transmucosal Drug Delivery Market Segment Percentages, by Application, 2022 (%)
Clinics
Hospitals
Others
Global Transdermal and Transmucosal Drug Delivery Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Transdermal and Transmucosal Drug Delivery Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Transdermal and Transmucosal Drug Delivery revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Transdermal and Transmucosal Drug Delivery revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
3M
Antares Pharma
Aveva Drug Delivery Systems
Corium International
DURECT
Pantec Biosolutions
Tapemark
Tesa Labtec
Outline of Major Chapters:
Chapter 1: Introduces the definition of Transdermal and Transmucosal Drug Delivery, market overview.
Chapter 2: Global Transdermal and Transmucosal Drug Delivery market size in revenue.
Chapter 3: Detailed analysis of Transdermal and Transmucosal Drug Delivery company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Transdermal and Transmucosal Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
